Search

Search Constraints

You searched for: Author/Creator Ames, Matthew M.

Search Results

1. A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: A children's oncology group phase 1 consortium study. Issue 9 (28th March 2013)

2. A phase I trial of MK‐2206 in children with refractory malignancies: A Children's Oncology Group study. Issue 7 (24th March 2014)

3. A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: A Children's Oncology Group phase I consortium study (ADVL0916)1. Issue 3 (9th August 2012)

4. A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance). (24th January 2019)

5. Characterization of Batracylin-induced Renal and Bladder Toxicity in Rats. (June 2015)

7. Evaluation of CYP2D6 enzyme activity using a 13C-dextromethorphan breath test in women receiving adjuvant tamoxifen. Issue 4 (April 2015)

8. Evaluation of CYP2D6 enzyme activity using a 13C-dextromethorphan breath test in women receiving adjuvant tamoxifen. Issue 4 (April 2015)

9. North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic‐based dosing of irinotecan, oxaliplatin, and capecitabine as first‐line therapy for patients with advanced small bowel adenocarcinoma. Issue 18 (10th May 2017)

10. Phase 2 trial of pemetrexed in children and adolescents with refractory solid tumors: A Children's Oncology Group study12. Issue 2 (28th June 2012)